Abstract Library

#3678 Complete remission of Necrolytic Migratory Erythema related to glucagonoma under octreotide therapy

Introduction: Glucagonomas are rare neuroendocrine tumors (NETs), generally diagnosed with locoregional involvement; it has heterogeneous survival with therapeutic approaches ranging from the use of somatostatin analogues, and cytoreductive surgery to PRRT.

Conference:

Presenting Author:

Authors: González Devia D, Rozo-Paz G, Chalela-Mantilla J, Aguirre Matallana D, Arias Amézquita F,

Keywords: Glucagonoma, Migratory necrolytic erythema, Octreotide, Overall survival, Neuroendocrine tumor,

#3656 Glucagonomas – Characteristics and treatment options based on a French multicenter cohort study

Introduction: Glucagonoma is a rare functional pancreatic neuroendocrine tumor (pNET).

Conference:

Presenting Author:

Authors: Perrier M, Brugel M, Walter T, Goichot B, Lièvre A,

Keywords: glucagonoma, neuroendocrine neoplasm, pancreas, necrolytic migratory erythema,

#3352 Exacerbation of Necrolytic Migratory Erythema after 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Introduction: Necrolytic migratory erythema (NME) is an uncommon skin disorder which is characterized by deep erythematous plaques with superficial blistering, erosions and crusts. NME is a cutaneous manifestation of glucagonoma. Glucagonoma syndrome is a paraneoplastic disease, caused by an excessive secretion of glucagon by pancreatic alpha cells.

Conference:

Presenting Author:

Authors: Ahmadi Bidakhvidi N, Vanden Bulcke A, Curvers S, de Haes P, de Hertogh G,

Keywords: glucagonoma, necrolytic migratory erythema, PRRT, 177Lu-DOTATATE, neuroendocrine tumor, pancreas,

#2775 Glucagonoma: Still a Misleading Disease and the Importance of Multidisciplinary Neuroendocrine Tumor Board

Introduction: Glucagonoma is a rare neuroendocrine tumor (NET) of the pancreatic alpha cells that results in the overproduction of the hormone glucagon. This entity is typically associated with a rash called necrolytic migratory erythema, weight loss and diabetes.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Parlagreco E

Authors: Parlagreco E, La Salvia A, Persano I, Pia A, Scagliotti G,

Keywords: glucagonoma, necrolytic migratory erithema, diagnostic delay, patient’s quality of life,

#1108 Regression of Paraneoplastic Optic Neuropathy Associated with Glucagonoma After Surgical Resection

Introduction: Glucagonomas-associated ocular manifestations have been exceptionally reported.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Defour L, De Mestier L, Diebold M, Arndt C, Kianmanesh R,

Keywords: Paraneoplastic syndrome, glucagonoma, optic neuropathy.,